375 related articles for article (PubMed ID: 10487616)
1. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer.
Barber MD; Ross JA; Voss AC; Tisdale MJ; Fearon KC
Br J Cancer; 1999 Sep; 81(1):80-6. PubMed ID: 10487616
[TBL] [Abstract][Full Text] [Related]
2. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement.
Barber MD; McMillan DC; Preston T; Ross JA; Fearon KC
Clin Sci (Lond); 2000 Apr; 98(4):389-99. PubMed ID: 10731472
[TBL] [Abstract][Full Text] [Related]
3. Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia.
Barber MD; Fearon KC; Tisdale MJ; McMillan DC; Ross JA
Nutr Cancer; 2001; 40(2):118-24. PubMed ID: 11962246
[TBL] [Abstract][Full Text] [Related]
4. Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.
Wigmore SJ; Barber MD; Ross JA; Tisdale MJ; Fearon KC
Nutr Cancer; 2000; 36(2):177-84. PubMed ID: 10890028
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the liver export protein synthetic response to feeding by an n-3 fatty-acid-enriched nutritional supplement is associated with anabolism in cachectic cancer patients.
Barber MD; Preston T; McMillan DC; Slater C; Ross JA; Fearon KC
Clin Sci (Lond); 2004 Apr; 106(4):359-64. PubMed ID: 14624668
[TBL] [Abstract][Full Text] [Related]
6. Compliance with nutrition prescription improves outcomes in patients with unresectable pancreatic cancer.
Bauer J; Capra S; Battistutta D; Davidson W; Ash S;
Clin Nutr; 2005 Dec; 24(6):998-1004. PubMed ID: 16140426
[TBL] [Abstract][Full Text] [Related]
7. Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer.
Cerchietti LC; Navigante AH; Castro MA
Nutr Cancer; 2007; 59(1):14-20. PubMed ID: 17927497
[TBL] [Abstract][Full Text] [Related]
8. Use of oral nutritional supplements in patients with Huntington's disease.
Trejo A; Boll MC; Alonso ME; Ochoa A; Velásquez L
Nutrition; 2005 Sep; 21(9):889-94. PubMed ID: 16087319
[TBL] [Abstract][Full Text] [Related]
9. The use of a protein and energy dense eicosapentaenoic acid containing supplement for malignancy-related weight loss in children.
Bayram I; Erbey F; Celik N; Nelson JL; Tanyeli A
Pediatr Blood Cancer; 2009 May; 52(5):571-4. PubMed ID: 19090549
[TBL] [Abstract][Full Text] [Related]
10. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.
Jatoi A; Rowland K; Loprinzi CL; Sloan JA; Dakhil SR; MacDonald N; Gagnon B; Novotny PJ; Mailliard JA; Bushey TI; Nair S; Christensen B;
J Clin Oncol; 2004 Jun; 22(12):2469-76. PubMed ID: 15197210
[TBL] [Abstract][Full Text] [Related]
11. Nutritional support and quality of life in stable chronic obstructive pulmonary disease (COPD) patients.
Planas M; Alvarez J; García-Peris PA; de la Cuerda C; de Lucas P; Castellà M; Canseco F; Reyes L
Clin Nutr; 2005 Jun; 24(3):433-41. PubMed ID: 15896431
[TBL] [Abstract][Full Text] [Related]
12. Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia.
Fearon KC; Barber MD; Moses AG; Ahmedzai SH; Taylor GS; Tisdale MJ; Murray GD
J Clin Oncol; 2006 Jul; 24(21):3401-7. PubMed ID: 16849754
[TBL] [Abstract][Full Text] [Related]
13. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study.
Saifullah A; Watkins BA; Saha C; Li Y; Moe SM; Friedman AN
Nephrol Dial Transplant; 2007 Dec; 22(12):3561-7. PubMed ID: 17623719
[TBL] [Abstract][Full Text] [Related]
14. Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: randomised trial.
Sánchez-Lara K; Turcott JG; Juárez-Hernández E; Nuñez-Valencia C; Villanueva G; Guevara P; De la Torre-Vallejo M; Mohar A; Arrieta O
Clin Nutr; 2014 Dec; 33(6):1017-23. PubMed ID: 24746976
[TBL] [Abstract][Full Text] [Related]
15. Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy.
Murphy RA; Mourtzakis M; Chu QS; Baracos VE; Reiman T; Mazurak VC
Cancer; 2011 Apr; 117(8):1775-82. PubMed ID: 21360698
[TBL] [Abstract][Full Text] [Related]
16. Effects of medroxyprogesterone acetate on food intake, body composition, and resting energy expenditure in patients with advanced, nonhormone-sensitive cancer: a randomized, placebo-controlled trial.
Simons JP; Schols AM; Hoefnagels JM; Westerterp KR; ten Velde GP; Wouters EF
Cancer; 1998 Feb; 82(3):553-60. PubMed ID: 9452274
[TBL] [Abstract][Full Text] [Related]
17. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids.
Moses AW; Slater C; Preston T; Barber MD; Fearon KC
Br J Cancer; 2004 Mar; 90(5):996-1002. PubMed ID: 14997196
[TBL] [Abstract][Full Text] [Related]
18. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial.
Fearon KC; Von Meyenfeldt MF; Moses AG; Van Geenen R; Roy A; Gouma DJ; Giacosa A; Van Gossum A; Bauer J; Barber MD; Aaronson NK; Voss AC; Tisdale MJ
Gut; 2003 Oct; 52(10):1479-86. PubMed ID: 12970142
[TBL] [Abstract][Full Text] [Related]
19. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
Young GS; Conquer JA; Thomas R
Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
[TBL] [Abstract][Full Text] [Related]
20. Nutritional treatment for acquired immunodeficiency virus infection using an enterotropic peptide-based formula enriched with n-3 fatty acids: a randomized prospective trial.
de Luis Román DA; Bachiller P; Izaola O; Romero E; Martin J; Arranz M; Eiros Bouza JM; Aller R
Eur J Clin Nutr; 2001 Dec; 55(12):1048-52. PubMed ID: 11781670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
